Abstract 2587: Dasatinib-induced reduction of tumor growth is accompanied by the changes in the immune profile in melanoma B16.OVA mouse modeldoi:10.1016/S0959-8049(14)50795-2M.IlanderC.HekimM.Vähä-KoskelaP.SavolaS.TähtinenSDOSEuropean Journal of Cancer...
895: Dasatinib-induced reduction of tumor growth is accompanied by the changes in the immune profile in melanoma B16.OVA mouse modeldoi:10.1016/s0959-8049(14)50795-2M. IlanderC. HekimM. Vh-KoskelaP. SavolaS. ThtinenA. HemminkiK. Porkka...